This site is intended for US health care professionals only.

IMPORTANT SAFETY INFORMATION

This site is intended for US health care professionals only.

WARNING: ABUSE AND DEPENDENCE

  • CNS stimulants (amphetamines and methylphenidate-containing products), including Vyvanse, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.
Full Safety Information Below

Vyvanse is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in patients ages 6 and above, and for the treatment of moderate to severe binge eating disorder (B.E.D.) in adults. Vyvanse is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Vyvanse for the treatment of obesity have not been established.

Co-pays for Prescription Drugs1

To help curb the rising cost of prescription drugs, insurers use a formulary, which includes the drugs the plan will cover. These drugs have been approved by the plan’s pharmacy and therapeutics committee (P&T), which is comprised of physicians, pharmacists, and other health care professionals. Many factors go into the committee’s decisions on which drugs to cover or limit access to, including clinical data, practice guidelines, efficacy, safety, and manufacturer price.

In addition to the formulary, payers employ a number of cost-sharing strategies and restrictions to help reduce prescription costs. Drugs usually fall under one of the following tiers, which determine their co-pays:

  • Preferred Generic: Lowest co-pay
  • Generic: Next lowest co-pay
  • Preferred Brand: Higher co-pay
  • Non-preferred Brand: Next highest co-pay
  • Specialty: Highest co-pay (usually a percentage)
  • Not Covered

Looking for Vyvanse formulary coverage and co-pay amounts? You can now search for this information by state and health plan.

Explore Now
Shire

All content of this Web site including text, images, graphics, sound files, and their arrangements, belongs to Shire and is protected by international copyrights laws. All other intellectual property rights are reserved. The content may not be copied for commercial use or distribution nor may these objects be downloaded, modified, or posted to other sites.

This site is intended solely for US residents and is governed solely by US laws and government regulations. Please see our online privacy policy for more information. While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.

AdChoices

S38422  04/18S38422  04/18S38422  04/18

You are about to leave vyvansepro.com.

Please be advised that Shire has no control over the content or presentation of the site you are about to view.

Cancel Continue
CLOSE
Scroll for additional Important Safety Info & see Full Prescribing Information.